Levetiracetam Tablet
Product Images NDC 76282-247

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 76282-247). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Str (Levetiracetam Tablets 1)

FDA Label Image

Levetiracetam 750 mg Tablets, Usp (Levetiracetam Tablets 10)

Levetiracetam Tablets, USP is a medication used to treat seizures. The usual dosage and storage instructions are included on the packaging insert. The medication should be dispensed in a child-resistant container and stored at 25°C (77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. The medication is manufactured for Exelan Pharmaceuticals, Inc. in Lawrenceville, GA 30046 and manufactured by InvaGen Pharmaceuticals, Inc. in Hauppauge, NY 11788.*

FDA Label Image

Fig 1 (Levetiracetam Tablets 2)

This appears to be a chart showing various percentages of patients, as well as percentages attributed to specific treatments (placebo, Levetiracetam at 1000mg/day, and Levetiracetam at 3000mg/day). It is unclear what the context or purpose of the chart is, as no further information is provided.*

FDA Label Image

Fig 2 (Levetiracetam Tablets 3)

This appears to be a chart or graph showing the percentages of patients in different treatment groups. The treatments are likely related to seizures or epilepsy since one of the groups is labeled with a medication name, Levetiracetam. The chart also shows the number of patients in each group.*

FDA Label Image

Fig 3 (Levetiracetam Tablets 4)

FDA Label Image

Fig 4 (Levetiracetam Tablets 5)

This is a table showing percentages of patients in a medical study. It compares placebo to a drug called Levetiracetam. The percentages given are 45%, 40%, 35%, 30%, 25%, and 20% for patients in both groups. There are also symbols for percent, at, and a registered trademark. In addition, there are specific percentages of 10% and 19.6% mentioned, but no context is given.*

FDA Label Image

Fig 6 (Levetiracetam Tablets 7)

This is a chart or table depicting the percentage of patients, indicated by numerical values, receiving either Placebo or Levetiracetam. The total number of patients included in the study appears to be 84. Further information or context is not available with only these details.*

FDA Label Image

Levetiracetam 250 mg Tablets, Usp (Levetiracetam Tablets 8)

The text contains a medication guide for Levetiracetam tablets, USP 250mg. The medication should be dispensed in a light-resistant container with a child-resistant closure by the pharmacist. The recommended storage temperature is at 25°C (77°F) with limited excursions permitted. The tablets are manufactured by InvaGen Pharmaceuticals, Inc. and distributed by Exelan Pharmaceuticals, Inc. in Lawrenceville, GA.*

FDA Label Image

Levetiracetam 500 mg Tablets, Usp (Levetiracetam Tablets 9)

Levetiracetam Tablets, USP is a prescription medication manufactured by InvaGen Pharmaceuticals, Inc. and distributed by Exelan Pharmaceuticals, Inc. The medication is enclosed in a container with a child-resistant closure and an attached medication guide. The package contains 120 tablets and must be stored at a controlled temperature between 15°C to 30°C (59°F to 86°F). Usual dosage instructions can be found in the package insert. Pharmacists are advised to dispense the medication in a tight and light-resistant container.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.